NCT01919671View on ClinicalTrials.gov

Tongxinluo Capsule in Ischemic Stroke Patients（TISS)

PHASE4CompletedINTERVENTIONAL
Enrollment

2,007

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Ischemic Stroke
Interventions
DRUG

Tongxinluo capsule

for 90 days

DRUG

placebo capsule

for 90 days

Trial Locations (1)

Unknown

Beijing TianTan Hospital,Capital Medical University, Beijing

All Listed Sponsors
lead

yongjun wang

OTHER_GOV

NCT01919671 - Tongxinluo Capsule in Ischemic Stroke Patients（TISS) | Biotech Hunter | Biotech Hunter